Stay updated on PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial
Sign up to get notified when there's something new on the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page.

Latest updates to the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; a minor administrative update with no changes to study content or user-facing information.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision v3.4.1 removed and v3.4.2 added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check35 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 in the page's version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedA new 'Show glossary' option appears, capitalization of several labels has updated (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and the revision identifier changed from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check57 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check78 days agoChange DetectedLocations section added with Arizona, California, New Jersey, Washington, and Wisconsin, indicating current recruitment sites. This reflects updated site recruitment information for the study.SummaryDifference0.6%

Stay in the know with updates to PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page.